Outpatient rituximab, ifosfamide, etoposide (R-IE) in patients older than 60 years with relapsed or refractory diffuse large B-cell lymphoma who are not candidates for stem cell transplantation
journal contribution
posted on 2020-01-01, 00:00authored byM Joshi, J Taper, C Forsyth, P Rowlings, P Campbell, P Crispin, M Harvey, C Underhill, A Bayley, K Byth, G Huang, M Hertzberg
Outpatient rituximab, ifosfamide, etoposide (R-IE) in patients older than 60 years with relapsed or refractory diffuse large B-cell lymphoma who are not candidates for stem cell transplantation